Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, Massachusetts
- Most recent report
- 8-K, filed Aug 5, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 873303
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 67
News 8 of 202
Prospectuses and Registrations 8 of 54
- S-8 Registration statement for an employee plan Jul 28, 2026
- S-8 Registration statement for an employee plan Jun 4, 2026
- S-8 Registration statement for an employee plan Aug 6, 2025
- S-3ASR Automatic shelf registration Mar 3, 2025
- S-8 Registration statement for an employee plan Aug 7, 2024
- S-8 POS Post-effective amendment to an employee plan registration Mar 28, 2024
- S-8 POS Post-effective amendment to an employee plan registration Mar 28, 2024
- S-8 POS Post-effective amendment to an employee plan registration Mar 28, 2024
Proxies 8 of 32
- DEFA14A Extra proxy material Apr 24, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2026
- DEFA14A Extra proxy material Apr 24, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2024
- DEFA14A Extra proxy material Apr 24, 2024
- DEFA14A Extra proxy material Apr 24, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2023
Ownership 8 of 604
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Sep 8, 2026
- 13F-HR Quarterly report of institutional holdings Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 7, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 31, 2026
Other 8 of 41
- ARS Annual report sent to shareholders Apr 24, 2026
- ARS Annual report sent to shareholders Apr 24, 2025
- ARS Annual report sent to shareholders Apr 24, 2024
- ARS Annual report sent to shareholders Apr 24, 2023
- UPLOAD Comment letter from SEC staff Apr 16, 2020
- CORRESP Reply to SEC staff Apr 15, 2020
- UPLOAD Comment letter from SEC staff Apr 13, 2020
- D Feb 28, 2020
Everything here comes from Sarepta Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.